Literature DB >> 1758805

The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

S C Bain1, P M Dodson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1758805      PMCID： PMC2399171          DOI： 10.1136/pgmj.67.792.922

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  65 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up.

Authors:  M B Murphy; P J Lewis; E Kohner; B Schumer; C T Dollery
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

Review 3.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.

Authors:  R A DeFronzo; E Ferrannini; V Koivisto
Journal:  Am J Med       Date:  1983-01-17       Impact factor: 4.965

Review 4.  New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.

Authors:  J A Colwell; P D Winocour; M Lopes-Virella; P V Halushka
Journal:  Am J Med       Date:  1983-11-30       Impact factor: 4.965

5.  Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

Authors:  U P Steinbrecher; J L Witztum
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

6.  Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women.

Authors:  H Kaji; M Kurasaki; K Ito; T Saito; K Saito; T Niioka; Y Kojima; Y Ohsaki; H Ide; M Tsuji
Journal:  Klin Wochenschr       Date:  1985-08-16

7.  The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.

Authors:  K M West; M M Ahuja; P H Bennett; A Czyzyk; O M De Acosta; J H Fuller; B Grab; V Grabauskas; R J Jarrett; K Kosaka
Journal:  Diabetes Care       Date:  1983 Jul-Aug       Impact factor: 19.112

8.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

Review 9.  Diabetic patients and beta-blockers after acute myocardial infarction.

Authors:  J Kjekshus; E Gilpin; G Cali; A R Blackey; H Henning; J Ross
Journal:  Eur Heart J       Date:  1990-01       Impact factor: 29.983

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.